TOP 10 Gastrointestinal care in North Haven, Connecticut

Jill Lacy is a renowned institution located at 6 Devine Street in North Haven, Connecticut, United States. Dr. Jill Lacy, the founder, is a Professor of Medicine in the Section of Medical Oncology at Yale School of Medicine, with over 30 years of experience as a practicing Medical Oncologist. Dr. Lacy is a graduate of Yale School of Medicine and is board-certified in Internal Medicine and Medical Oncology. During the AIDS epidemic, Dr. Lacy's early career focused on research related to Epstein Barr virus-mediated oncogenesis and HIV-associated malignancies. In recent years, her clinical practice has been dedicated to caring for patients with gastrointestinal malignancies. Dr. Lacy's current research focuses on therapeutic clinical trials in GI malignancies, including gastroesophageal, pancreatic, and colorectal cancers. She is the principal investigator on numerous studies and has served on national committees aimed at enhancing the education of Medical Oncology trainees and increasing diversity in the field of Oncology.

Jeremy Kortmansky, MD is a specialized medical institution located at 6 Devine Street in North Haven, Connecticut, United States. Dr. Kortmansky focuses on the treatment of gastrointestinal neuroendocrine tumors, which are cancers that develop in the digestive tract. These tumors can form in various parts of the gastrointestinal system, such as the small intestine, stomach, rectum, appendix, and more. The institution also provides care for gastrointestinal cancers, which occur when DNA changes lead to the growth of malignant cells along the gastrointestinal tract. Patients can learn about the symptoms and treatment options available for these types of cancers.

Yale Medicine Digestive Diseases, located at 8 Devine Street in North Haven, Connecticut, is a renowned health institution specializing in the diagnosis and treatment of digestive disorders. Patients at Yale Medicine have access to world-renowned doctors who provide cutting-edge care and innovative treatments. Recently, the institution has been at the forefront of groundbreaking developments in the field, such as the FDA approval of Rezdiffra, the first drug for NASH, a form of fatty liver disease. Additionally, their cardiologists may prescribe Semaglutide (Wegovy) to aid in weight management and improve overall health. Yale Medicine Digestive Diseases is dedicated to providing comprehensive care and improving patient outcomes through a multidisciplinary approach.